MiR‐375‐mediated suppression of engineered coxsackievirus B3 in pancreatic cells-Reference-Cited by-同舟云学术

MiR‐375‐mediated suppression of engineered coxsackievirus B3 in pancreatic cells

Published:2019-11-07 Issue:4 Volume:594 Page:763-775
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Pryshliak Markian¹,Hazini Ahmet¹,Knoch Klaus²,Dieringer Babette¹,Tolksdorf Beatrice¹,Solimena Michele²,Kurreck Jens¹,Pinkert Sandra³,Fechner Henry¹^ORCID

Affiliation:

1. Department of Applied Biochemistry Institute of Biotechnology Technische Universität Berlin Germany

2. Paul Langerhans Institute Dresden Helmholtz Center Munich Faculty of Medicine University Hospital Carl Gustav Carus Technische Universität Dresden Germany

3. Corporate Member of Freie Universität Berlin Berlin Institute of Health (BIH) Institute of Biochemistry Charité ‐ Universitätsmedizin Berlin Humboldt‐Universität zu Berlin Germany

Funder

Bundesministerium für Bildung und Forschung

Wilhelm Sander-Stiftung

European Federation of Pharmaceutical Industries and Associations

Juvenile Diabetes Research Foundation United States of America

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.13647